Speciality pharmaceutical company Espero Pharmaceuticals and cardiovascular drugs announced Armetheon plan to merge and create new venture Espero pharmaceutical . The new company will focus on the development of drugs for unmet cardiovascular indications and will be headed by Quang Pham , the founder of Espero . The merger should be completed by the end of the second quarter of 2019 .
Speciality pharmaceutical company Espero Pharmaceuticals and cardiovascular drugs firm Armetheon plan to merge and create new venture Espero BioPharma. The new company will focus on the development of drugs for unmet cardiovascular indications and will be led by Quang Pham, the founder of Espero. The merger should be completed by the end of the second quarter of 2017.